DRKS00023581已完成不适用
Myeloproliferative Neoplasms - AYAs and Elderly: Two Sides of the Same Coin? A multicenter non-interventional study of East German Hematology and Oncology Study Group (OSHO) - MAry
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 127
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Age = 18 years
- •- Signed informed consent
- •- Patients must fulfil WHO diagnostic criteria fpr myelofibrosis (MF), essential thrombocythemia (ET), or polycythemia vera (PV)
排除标准
- •- Limited legal capacity or lack of legal capacity
- •- Age < 18 years
- •- BCR-ABL-positive chronic myeloid leukemia (CML)
研究者
相似试验
已完成
不适用
Study to to evaluate the occurrence of Myeloproliferative neoplasm (a type of disease in which the bone marrow makes too many RBC, platelets, or certain WBC) & to characterize treatment patterns & burden/ symptoms of illness under routine medical practiceCTRI/2014/05/004598ovartis Healthcare Pvt Ltd
已完成
不适用
Genetic abnormalities in myeloproliferative neoplasmsJPRN-UMIN000016132Mie University, Department of Hematology and Oncology50
已完成
不适用
Investigational study for elderly acute myelocytic leukemiaacute myelocytic leukemiaJPRN-C000000224Japan Adult Leukemia Study Group288
进行中（未招募）
1 期
The AML18 Trial is an intensive chemotherapy trial for patients primarily over the age of 60 with AML and High Risk Myelodysplastic disease. This randomised, up to 2000 patient trial will evaluate the effect of adding novel treatment combinations to standard chemotherapy.Acute Myeloid LeukaemiaHigh Risk Myelodysplastic SyndromeMedDRA version: 20.0Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2013-002730-21-GBCardiff University2,000
进行中（未招募）
1 期
The AML18 Trial is an intensive chemotherapy trial for patients primarily over the age of 60 with AML and High Risk Myelodysplastic disease. This randomised, up to 2000 patient trial will evaluate the effect of adding novel treatment combinations to standard chemotherapy.Acute Myeloid LeukaemiaHigh Risk Myelodysplastic SyndromeMedDRA version: 20.0Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2013-002730-21-DKCardiff University2,000